Γιατί η Σκάρλετ άνοιξε πόλεμο για τη «Μαύρη Χήρα» protagon.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from protagon.gr Daily Mail and Mail on Sunday newspapers.
MetroHealth Cancer Center partners with The Gathering Place
MetroHealth Cancer Center partners with The Gathering Place
Print
MetroHealth has partnered with The Gathering Place, a nonprofit organization that supports and educates individuals and families coping with the impact of cancer, to bring those support services to MetroHealth s Cancer Center two days a week, according to a news release. We are so fortunate to have The Gathering Place in our community, an organization that is dedicated to and has the expertise in providing an incredible array of services to survivors of cancer and their families, said Dr. Benjamin Li, MetroHealth Cancer Center director, in a provided statement.
Personal trainers red in the face over new council outdoor fitness permit scheme in Wyre garstangcourier.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from garstangcourier.co.uk Daily Mail and Mail on Sunday newspapers.
MetroHealth forms Center for Cancer Research
Print
A newly formed MetroHealth Center for Cancer Research brings together nationally and internationally recognized researchers to focus on more than curing one of the most feared diseases.
Backed by millions of dollars in support and grants and dozens of research assistants, the team will also focus on ending racial, ethnic, social and economic inequities that impact cancer diagnosis and treatment, according to a news release. We re doing this for the patients we serve, to ensure that they have the latest advances in cancer care and that they are able to participate in cutting-edge clinical trials in cancer care, said Dr. Bernard Boulanger, MetroHealth s executive vice president and chief clinical officer, in a provided statement.
Italian firm brings bacterial conjunctivitis drug to Asia
Italian firm brings bacterial conjunctivitis drug to Asia 18 January 2021 | News NTC014 seeks to provide physicians with rational treatment for moderate to severe bacterial conjunctivitis, a common eye infection
Source credit: Shutterstock
NTC, an international R&D-focused pharmaceutical company based in Italy, and Zhaoke (Hong Kong) Ophthalmology Pharmaceuticals Limited, have fully integrated the ophthalmology platform with a leading foundation in eye care, announced its agreement for an exclusive license and distribution rights to NTC014, an innovative fixed combination of quinolone antibiotic and NSAID eye drops. Zhaoke will commercialise NTC014 in the People s Republic of China , Hong Kong , Macao , Taiwan, ASEAN countries and South Korea .